Sector Gamma As Sangamo Therapeutics, Inc Transaction History

Sector Gamma As

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 11, 2020	SELL	$5.05 - $8.85 $1.07 Million - $1.87 Million	-211,698 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$8.03 - $11.7 $321,200 - $468,000	-40,000 Reduced 15.89%	211,698 $1.77 Million
Q2 2019 Jul 31, 2019	BUY	$8.75 - $13.03 $112,358 - $167,318	12,841 Added 5.38%	251,698 $2.71 Million
Q1 2019 May 13, 2019	BUY	$7.72 - $12.81 $647,684 - $1.07 Million	83,897 Added 54.14%	238,857 $2.28 Million
Q3 2018 Nov 15, 2018	BUY	$13.05 - $19.05 $910,354 - $1.33 Million	69,759 Added 81.88%	154,960 $2.63 Million
Q3 2018 Nov 08, 2018	SELL	$13.05 - $19.05 $793,426 - $1.16 Million	-60,799 Reduced 41.64%	85,201 $1.44 Million
Q2 2018 Aug 02, 2018	BUY	$13.9 - $19.8 $695,000 - $990,000	50,000 Added 52.08%	146,000 $2.07 Million
Q1 2018 May 09, 2018	BUY	$16.7 - $26.35 $1.6 Million - $2.53 Million	96,000 New	96,000 $1.82 Million

135

86.5M

35.9K

156K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $312M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

Stay updated on Sector Gamma As with notifications on news.